Commitments and Contingencies (Details)															1 Months Ended	3 Months Ended		6 Months Ended
	Oct. 01, 2021 USD ($)	Aug. 10, 2021 USD ($)	Jul. 23, 2021 USD ($)	Jul. 01, 2021 USD ($) $ / shares shares	Mar. 31, 2021 USD ($)	Jan. 01, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 07, 2020 USD ($) shares	Dec. 01, 2020 shares	Jul. 23, 2020 USD ($) item	Feb. 01, 2020 USD ($)	Jun. 05, 2019 USD ($) shares	Jun. 01, 2019 USD ($)	Aug. 04, 2016 USD ($)	Apr. 30, 2020 USD ($)	Jun. 30, 2021 USD ($) $ / shares	Jun. 30, 2020 USD ($)	Jun. 30, 2021 USD ($) $ / shares	Jun. 30, 2020 USD ($)	Apr. 30, 2021 USD ($)	Apr. 01, 2021 $ / shares shares	Feb. 16, 2021 $ / shares shares	Jan. 31, 2021 $ / shares	Jan. 16, 2021 $ / shares shares	Jan. 31, 2020 shares
Other Commitments [Line Items]
Issuance of warrants for consulting fees																$ 52,681		$ 396,848
Warrants term																							5 years
Funding receivable in year two							$ 127,445
Clinical trial expenses																$ 986,280	$ 600,065	$ 2,138,060	$ 993,310
Monthly installment of annual consulting fee											$ 17,500
Warrants to purchase shares of common stock | shares								52,983
Exercise price of warrants | $ / shares																$ 0.01		$ 0.01					$ 0.01
Subsequent events
Other Commitments [Line Items]
Separation benefits reimbursed by Metuchen pursuant to Merger		$ 213,700
Consulting Agreement with SM Capital Management, LLC [Member]
Other Commitments [Line Items]
Contract Payments, Term														1 year
Annual consulting fee														$ 120,000
Consultancy fees																$ 30,000		$ 60,000
Monthly installment of annual consulting fee														$ 10,000
Consulting Agreement with Katalyst Securities LLC [Member]
Other Commitments [Line Items]
Consultancy fees																153,867		459,700
Payments for consulting per month													$ 25,000
Warrants term									5 years
Warrants term following the effective date									3 months
Monthly installment of annual consulting fee						$ 20,000
Warrants to purchase shares of common stock | shares									4,500												4,500			25,000
Exercise price of warrants | $ / shares																					$ 8.80			$ 11.46
Consulting Agreement with Katalyst Securities LLC [Member] | Subsequent events
Other Commitments [Line Items]
Warrants to purchase shares of common stock | shares				4,500
Exercise price of warrants | $ / shares				$ 9.76
Consulting Agreement with GP Nurmenkari, Inc [Member]
Other Commitments [Line Items]
Consultancy fees																54,815		189,148
Warrants term												5 years
Warrants term following the effective date											3 months	3 months
Monthly installment of annual consulting fee						$ 12,000						$ 8,000
Warrants to purchase shares of common stock | shares												1,200									2,500	10,000			2,500
Exercise price of warrants | $ / shares																					$ 8.80	$ 11.46
Consulting Agreement with GP Nurmenkari, Inc [Member] | Subsequent events
Other Commitments [Line Items]
Issuance of warrants for consulting fees	$ 5,800
Monthly installment of annual consulting fee				$ 20,000
Warrants to purchase shares of common stock | shares				5,800
Exercise price of warrants | $ / shares				$ 9.76
2020 Services Agreement
Other Commitments [Line Items]
Target enrollment of study subjects | item										100
Total estimated budget for the services										$ 9,600,000
Pass-through expenses										266,000
Services fees										943,000
Investigator/institute fees										$ 314,000
Threshold period of prior written notice to terminate agreement										60 days
Funding received															$ 1,000,000.0			1,000,000.0
Funding receivable in year two																				$ 1,700,000
Amount funded against the total trial cost																3,900,000		3,900,000
Clinical trial expenses			$ 4,000,000.0													745,000		1,600,000
Clinical expenses credited against WCT prepayments																		30
WCT prepayment																2,021,000,000		2,021,000,000
WCT prepayments included as a prepaid expense and other current assets																500,000		500,000
WCT payments included in accounts payable																$ 468,000		468,000
2020 Services Agreement | National Institutes of Health
Other Commitments [Line Items]
Total estimated budget for the services										$ 6,900,000
Amount of award received										$ 2,700,000								2,700,000
Clinical trial expenses																		$ 4,000,000.0
Employment agreement with Alan J. Tuchman, M.D
Other Commitments [Line Items]
Initial annual base salary								$ 222,000
Annual discretionary bonus payable (as a percent)								50.00%
Options granted to purchase shares of common stock as a percent of Company's outstanding shares of common stock immediately following the Spin-Off						1.00%
Minimum percentage of annualized salary payable if the employee is termination within six months from start date								50.00%
Employment agreement with Alan J. Tuchman, M.D | If employee is terminated after six months but within one year from Start Date
Other Commitments [Line Items]
Number of months base salary payable if the employee is terminated								1
Employment agreement with Alan J. Tuchman, M.D | First anniversary from Start Date
Other Commitments [Line Items]
Options granted, vesting percentage								25.00%
Employment agreement with Alan J. Tuchman, M.D | Second anniversary from Start Date
Other Commitments [Line Items]
Options granted, vesting percentage								25.00%
Employment agreement with Alan J. Tuchman, M.D | Third anniversary from Start Date
Other Commitments [Line Items]
Options granted, vesting percentage								25.00%
Employment agreement with Alan J. Tuchman, M.D | Fourth anniversary from Start Date
Other Commitments [Line Items]
Options granted, vesting percentage								25.00%
Charles Ryan Separation Agreement
Other Commitments [Line Items]
Annual discretionary bonus payable (as a percent)								50.00%
Number of months base salary payable as of the Separation Date								12
Total base salary payable upon Separation								$ 425,000
Cash bonus payable upon Separation								$ 225,000
Period following the Separation Date to pay COBRA premiums								12 months
Total commitment								$ 660,000
Separation benefits reimbursed by Metuchen pursuant to Merger					$ 99,000		$ 332,000
Charles Ryan Separation Agreement | Subsequent events
Other Commitments [Line Items]
Separation benefits reimbursed by Metuchen pursuant to Merger		$ 427,400